Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 trial evaluating a monoclonal antibody therapy in patients with prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Monoclonal antibody therapy

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED